135 related articles for article (PubMed ID: 14744774)
1. A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization.
Olsson AK; Larsson H; Dixelius J; Johansson I; Lee C; Oellig C; Björk I; Claesson-Welsh L
Cancer Res; 2004 Jan; 64(2):599-605. PubMed ID: 14744774
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions.
Lee C; Dixelius J; Thulin A; Kawamura H; Claesson-Welsh L; Olsson AK
Exp Cell Res; 2006 Aug; 312(13):2547-56. PubMed ID: 16769050
[TBL] [Abstract][Full Text] [Related]
3. Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein.
Dixelius J; Olsson AK; Thulin A; Lee C; Johansson I; Claesson-Welsh L
Cancer Res; 2006 Feb; 66(4):2089-97. PubMed ID: 16489009
[TBL] [Abstract][Full Text] [Related]
4. The anti-angiogenic His/Pro-rich fragment of histidine-rich glycoprotein binds to endothelial cell heparan sulfate in a Zn2+-dependent manner.
Vanwildemeersch M; Olsson AK; Gottfridsson E; Claesson-Welsh L; Lindahl U; Spillmann D
J Biol Chem; 2006 Apr; 281(15):10298-304. PubMed ID: 16436387
[TBL] [Abstract][Full Text] [Related]
5. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.
Simantov R; Febbraio M; Crombie R; Asch AS; Nachman RL; Silverstein RL
J Clin Invest; 2001 Jan; 107(1):45-52. PubMed ID: 11134179
[TBL] [Abstract][Full Text] [Related]
6. Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo.
Staton CA; Brown NJ; Rodgers GR; Corke KP; Tazzyman S; Underwood JC; Lewis CE
Blood; 2004 Jan; 103(2):601-6. PubMed ID: 14512300
[TBL] [Abstract][Full Text] [Related]
7. Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin.
Klenotic PA; Huang P; Palomo J; Kaur B; Van Meir EG; Vogelbaum MA; Febbraio M; Gladson CL; Silverstein RL
Am J Pathol; 2010 Apr; 176(4):2039-50. PubMed ID: 20167858
[TBL] [Abstract][Full Text] [Related]
8. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
Dhanabal M; LaRochelle WJ; Jeffers M; Herrmann J; Rastelli L; McDonald WF; Chillakuru RA; Yang M; Boldog FL; Padigaru M; McQueeney KD; Wu F; Minskoff SA; Shimkets RA; Lichenstein HS
Cancer Res; 2002 Jul; 62(13):3834-41. PubMed ID: 12097297
[TBL] [Abstract][Full Text] [Related]
9. Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein.
Thulin A; Ringvall M; Dimberg A; Kårehed K; Väisänen T; Väisänen MR; Hamad O; Wang J; Bjerkvig R; Nilsson B; Pihlajaniemi T; Akerud H; Pietras K; Jahnen-Dechent W; Siegbahn A; Olsson AK
Mol Cancer Res; 2009 Nov; 7(11):1792-802. PubMed ID: 19903770
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.
Pike SE; Yao L; Setsuda J; Jones KD; Cherney B; Appella E; Sakaguchi K; Nakhasi H; Atreya CD; Teruya-Feldstein J; Wirth P; Gupta G; Tosato G
Blood; 1999 Oct; 94(7):2461-8. PubMed ID: 10498619
[TBL] [Abstract][Full Text] [Related]
12. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
13. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
[TBL] [Abstract][Full Text] [Related]
14. Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma.
Hayashi K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Amoh Y; Hoffman RM; Bouvet M
J Surg Res; 2007 Jun; 140(2):165-70. PubMed ID: 17418866
[TBL] [Abstract][Full Text] [Related]
15. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.
Bråkenhielm E; Veitonmäki N; Cao R; Kihara S; Matsuzawa Y; Zhivotovsky B; Funahashi T; Cao Y
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2476-81. PubMed ID: 14983034
[TBL] [Abstract][Full Text] [Related]
17. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
18. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
19. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
20. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
